CARMA Therapeutics' Debt Round

CARMA Therapeutics raised a round of funding on June 12, 2017.

CARMA Therapeutics is a pre-clinical stage biotechnology company developing cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).…

Articles about CARMA Therapeutics' Debt Round: